FHD-286 induces differentiation and lethality in AML cells with MLL1r or mtNPM1 by disrupting chromatin accessibility and downregulating key factors such as c-Myc, PU.1, and CDK4/6. This evidence concerns the gene SPI1 and acute myeloid leukemia.